arrow
V

Vikas Ostwal

Tata Memorial Centre
H指数:21
被引数:1,709

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[18F]-Fluorodeoxyglucose positron emission tomography in grade 1-2 pancreatic neuroendocrine tumors: Prognostic in grade 2, not predictive of systemic therapy benefit

[18F]-氟代脱氧葡萄糖正电子发射断层扫描在1-2级胰腺神经内分泌肿瘤中的应用:在2级中具有预后价值,但不预测系统性治疗效果

Surgery
IF2.7
2026-09-010
PRE
Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers

开发一种用于预测老年胃肠道肿瘤患者相关治疗相关不良事件的新模型

2025-12-050
PRE
Hospital-based gallbladder cancer registry from a high-volume referral cancer centre in India: Insights into epidemiology and roadmap for enhancing cancer care

来自印度一家高容量转诊癌症中心基于医院的胆囊癌登记研究:关于流行病学和提升癌症护理的路线图

2025-11-010
PRE
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium − 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

PReCedeNT试验:一项III期随机对照试验,比较镥-177 DOTATATE肽受体放射性核素治疗(PRRT)联合化疗与PRRT单药治疗在FDG摄取阳性、分化良好的胃肠胰神经内分泌肿瘤(GEP-NETs)中的疗效。

2025-10-300
OAAI
Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers.

开发一种新型预测列线图以预防胆囊癌中的“无效手术”:一项对1196例切除的胆囊癌的单中心分析。

2025-10-060
PRE
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India
2024-12-010
PRE
Realizing Textbook Outcomes Following Liver Resection for Hepatic Neoplasms with Development and Validation of a Predictive Nomogram

通过开发和验证预测列线图来实现肝肿瘤肝切除术后的教科书结果

2024-08-053
OAAI
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
2024-07-272
OAAI
Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India
2024-05-011
OA
A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/ 5-fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers
2023-11-010
OA